2025. Patients With Atopic Dermatitis Using Oral Contraceptive Pills or Hormone Replacement Therapy: Long-Term Safety of Upadacitinib for Major Adverse Cardiovascular Events, Venous Thromboembolism, or Malignancy (Excluding Nonmelanoma Skin Cancer). SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s613. DOI:https://doi.org/10.25251/stfagt72.